| Financial Year |
March 31 2023 |
| Monetary Funds |
461,206,906.90 |
| Held-for-trading Financial Assets |
128,000,000.00 |
| Notes Receivable |
144,335,170.82 |
| Accounts Receivable |
1,343,055,574.53 |
| Advances to Suppliers |
26,924,983.63 |
| Other Receivables |
9,099,656.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
635,354,901.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,230,363.21 |
| Other Current Assets |
24,199,766.27 |
| Total Current Assets |
3,112,468,447.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,950,198.71 |
| Long-term Equity Investment |
2,077,376,652.74 |
| Investment Properties |
93,048,174.84 |
| Fixed Assetes |
1,934,188,079.48 |
| Under-construction Projects |
296,442,899.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
300,192,175.93 |
| R&D expenses |
-- |
| Goodwill |
146,571,634.81 |
| Long-Term Deferred and Prepaid Expenses |
302,061,796.24 |
| Deferred Income Tax Assets |
87,173,254.14 |
| Other Non-Current Assets |
94,756,227.49 |
| Sub-Total of Non-Current Assets |
5,527,995,275.63 |
| Total Assets |
8,640,463,723.26 |
| Short-Term Loans |
692,893,588.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
928,214,231.30 |
| Accounts Payable |
1,026,486,198.33 |
| Accounts Received In Advance |
1,855,985.36 |
| Employee Compensation Payable |
50,363,885.58 |
| Taxes Payable |
55,107,494.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
126,747,383.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
81,031,476.40 |
| Other Current Liabilities |
58,074,761.20 |
| Sub-Total of Current Liabilities |
3,328,769,676.70 |
| Long-term Loans |
316,272,107.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,383,016.30 |
| Deferred Income Tax Liabilities |
86,807,433.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
583,163,513.05 |
| Total Liabilities |
3,911,933,189.75 |
| Paid-In Capital(Or Share Stock) |
380,030,933.00 |
| Capital Surplus |
2,013,601,857.10 |
| Surplus Reserve |
190,015,466.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,141,268,140.12 |
| Minority Stockholder's Interest |
3,570,186.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,724,960,346.66 |
| Owner's Equity（Stockholder's Equity） |
4,728,530,533.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,640,463,723.26 |
